CLN5 and osteoradionecrosis: Other concepts, such as local growth factor delivery (VEGF, BMPs) or the use of vasculoprotective agents like pentoxifylline and tocopherol, are extrapolations from their promise in animal models (147) or their use in other ischemic conditions like osteoradionecrosis (148, 149).